MOESM2 of Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases

dataset

posted on 2019-10-22, 19:05 authored by Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Almudena Pardo-Mateos, Andrea Malfettone, José Pérez-García, Antonio Llombart-Cussac, Javier Cortés, Marc Moltó-Abad, Cecilia Muñoz-Delgado, Marta Pérez-Quintana, Jordi Pérez-López

Additional file 2. This file includes all the references screened in the systematic review and the reason for exclusion.

History

Usage metrics

Keywords

Systematic review Meta-analysis Case reports Clinical studies Mucopolysaccharidosis type II Enzyme replacement therapy Evidence-based medicine

Licence

CC BY + CC0

MOESM2 of Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases

History

Usage metrics

Categories

Keywords

Licence

Exports